Risk factors for colon adenomas recurrence after endoscopic mucosal resection

Aim: to identify risk factors for neoplasms recurrence removed by endoscopic mucosal resection (EMR).

Patients and methods: the single-center retrospective observational study included 207 patients with 260 benign colon neoplasms. There were 95 (45.9%) males and 112 (54.1%) females. The median age of the patients was 67 (27-80) years. The results obtained were assessed using following criteria: morbidity rate, complication type, hospital stay, tumor site, number of neoplasms in colon, lateral growth, fragmentation rate, technical difficulties (mucosal fold convergence)during surgery, grade of dysplasia, recurrence rate.

Results: intraoperative fragmentation of the neoplasms during mucosectomy occurred in 48/260 (18.5%) cases. Postoperative complications within the period of up to 30 days occurred in 13/207 (6.3%) patients. The most frequent 9 (4.2%) postoperative complication arising after mucosectomy was post-polypectomy syndrome. Another 4 (2.0%) patients produced bleeding after the surgery, which required repeated endoscopic procedure. No mortality occurred. The tumor size exceeding 25 mm (Exp (B) = 0.179; 95% CI = 0.05-0.7; p = 0.014), severe dysplasia (Exp (B) = 0.113; 95% CI = 0.03-0.4; p = 0.001) and fold convergence (Exp (B) = 0.2; 95% CI = 0.07-0.7; p = 0.015) are independent risk factors for disease recurrence.

Conclusion: mucosectomy is indicated for colon adenomas if its size does not exceed 25 mm and can be removed en bloc.

1. Kaprin A. D., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow: mnioi. P.A. Herzen (branch FGBU "MICR" of Minzdrav of Russia), 2019. [in Russ.].

2. Kashchenko V.A., Volkova E.S., Lobach S.M., Vanyan V.A. Screening of colorectal cancer. Clinical hospital. 2019; no.1 (27), pp. 18-23. [in Russ.].

3. Buchner A.M., Guamer-Argente C., Ginsberg G.G. Outcomes of EMR of defiant colorectal lesions directed to an endoscopy referral center. Gastrointest Endosc. 2012; 76(2):255-263.

4. Armashov V.P., Armashov O.Yu., Pavlenko V.V., et al. Results of endoscopic treatment of epithelial polypoid neoplasms of the colon and rectum. Evidence-Based gastroenterology. 2019; v.8, no.1, pp.43. [in Russ.].

5. Galimov O.V., Khanov V.O., Karimov M.A. et al. Gastrointestinal benign tumor treatment experience. The Bulletin of Contemporary Clinical Medicine. 2020; no.13(2), pp.36-41. [in Russ.]. DOI: 10.20969/VSKM.2020.13(2).36-41

6. Ortner M.A., Dorta G., Blum A.L. et al. Endoscopic interventions for preneoplastic and neoplastic lesions: mucosectomy, argon plasma coagulation, and photodynamic therapy. Dig Dis. 2002; 20(2):167-72.

7. Tajika M., Niwa Y., Bhatia V. et al. Comparison of endoscopic submucosal dissection and endoscopic mucosal resection for large colorectal tumors. Eur J Gastroenterol Hepatol. 2011; 23(11):1042-1049.

8. Karpov O.E., Vetshev P.S., Maady A.S. et al. Innovative endoscopic technologies in multi-field medical facility Pirogov Russian Journal of Surgery. 2017; no.5, pp.52-59. [in Russ.]. doi.org/10.17116/hirurgia2017552-59

9. Tanaka S., Kashida H., Saito Y. et al. Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig Endosc. 2020; 32(2):219-239.

10. Corley D.A., Jensen C.D., Marks A.R. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013; 11(2):172-180.

11. Ahlenstiel G., Hourigan L.F., Brown G. et al. Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon. Gastrointest Endosc. 2014; 80:668-676.

12. Jayanna, M., Burgess N.G., Singh R. et al. Cost analysis of endoscopic mucosal resection vs surgery for large laterally spreading colorectal lesions. Clin Gastroenterol Hepatol. 2016; 14: 271-278.

13. Keswani R.N., Law R., Ciolino J.D. et al. Adverse events after surgery for benign colon polyps are common and associated with increased length of stay and costs. Gastrointest Endosc. 2016; 84:296-303.

14. Moss A., Nalankilli K. Completing the circle of informed consent for EMR versus surgery for nonmalignant large or complex colorectal polyps. Gastrointest Endosc. 2016; 84:304-306.

15. Mtvralashvili D.A., Likutov A.A., Veselov V.V., et al. Does lesion site affects outcomes of endoscopic submucosal dissection for colon neoplasia? Koloproktologia. 2019; no.18(2(68), pp.33-48. [in Russ.]. https://doi.org/10.33878/2073-7556-2019-18-2-33-41

16. Fukami N. Surgery Versus Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for Large Polyps: Making Sense of When to Use Which Approach. Gastrointest Endosc Clin N Am. 2019;29(4): 675-685.

17. Puli S.R., Kakugawa Y., Gotoda T. et al. Meta-analysis and systematic review of colorectal endoscopic mucosal resection. World J Gastroenterol. 2009; 15:4273-4277.

18. Moss A., Williams S.J., Hourigan L.F. et al. Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut. 2015;64: 57-65.

19. Oka S., Tanaka S., Saito Y. et al. Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol. 2015;110: 697-707.

20. Khomyakov E.A., Chernyshov S.V., Rybakov E.G. et al. The results of 600 transanal endoscopic surgeries of rectal adenomas and adenocarcinomas. Koloproktologia. 2019; no.18(3(69), pp.20-40. [in Russ.]. https://doi.org/10.33878/2073-7556-2019-18-3-20-40

21. Ahmad, N.A., Kochman M.L., Long W.B. et al. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc. 2002; 55: 390-396.

22. Saito, Y., Uraoka T., Yamaguchi Y. et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc. 2010; 72: 1217-1225.